Eyenovia Inc (EYEN)
1.01
+0.07
(+7.74%)
USD |
NASDAQ |
May 03, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Eyenovia Free Cash Flow: -27.81M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -27.81M |
September 30, 2023 | -27.06M |
June 30, 2023 | -26.49M |
March 31, 2023 | -25.47M |
December 31, 2022 | -25.98M |
September 30, 2022 | -26.59M |
June 30, 2022 | -25.23M |
March 31, 2022 | -25.97M |
December 31, 2021 | -22.49M |
September 30, 2021 | -10.75M |
June 30, 2021 | -7.148M |
March 31, 2021 | -5.552M |
December 31, 2020 | -6.646M |
Date | Value |
---|---|
September 30, 2020 | -16.20M |
June 30, 2020 | -18.09M |
March 31, 2020 | -19.20M |
December 31, 2019 | -19.09M |
September 30, 2019 | -19.05M |
June 30, 2019 | -18.72M |
March 31, 2019 | -16.62M |
December 31, 2018 | -13.11M |
September 30, 2018 | -11.01M |
June 30, 2018 | -8.249M |
March 31, 2018 | -6.251M |
December 31, 2017 | -4.741M |
Free Cash Flow Range, Past 5 Years
-27.81M
Minimum
Dec 2023
-5.552M
Maximum
Mar 2021
-19.66M
Average
-19.20M
Median
Mar 2020
Free Cash Flow Benchmarks
NovaBay Pharmaceuticals Inc | -4.15M |
Alpine Immune Sciences Inc | -79.50M |
Lantern Pharma Inc | -14.37M |
Oragenics Inc | -7.291M |
MAIA Biotechnology Inc | -13.07M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -6.322M |
Cash from Investing (Quarterly) | -0.1452M |
Cash from Financing (Quarterly) | 0.6143M |
Free Cash Flow Per Share (Quarterly) | -0.1335 |
Free Cash Flow to Equity (Quarterly) | -6.652M |
Free Cash Flow Yield | -67.12% |